Evidence map›Paper›PMID 21254377›Full record

ArticlePediatric blood & cancer2012

Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia.

Emily S Tonorezos, Gloria L Vega, Charles A Sklar, Joanne F Chou, Chaya S Moskowitz, Qianxing Mo, Timothy S Church, Robert Ross, Peter M Janiszewski, Kevin C Oeffinger

Open access · greenAbstract read
In one paragraph

Article in Pediatric blood & cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2021
    Pooled it
  2. Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Emily S TonorezosDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Gloria L Vega
Charles A Sklar
Joanne F Chou
Chaya S Moskowitz
Qianxing Mo
Timothy S Church
Robert Ross
Peter M Janiszewski
Kevin C Oeffinger
Memorial Sloan Kettering Cancer Center · USQueen's University · CAPennington Biomedical Research Center · USSouthwestern Medical Center

Funding

NORTH AND CENTRAL TEXAS CTSA FOR PEDIATRIC RESEARCHUL1RR024982 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2007 to 2011
$27.9M
XU 40468 IN HYPERCHOLESTEROLEMIAM01RR000633 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 1985 to 2007
$21.0M
PROJECT ALLIFE-EXERCISE AND LEUKEMIA SURVIVORSR01CA100474 · NCI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI OEFFINGER, KEVIN CHARLES · 2003 to 2006
$1.7M
Survivorship: Mentoring and Bridging Primary Care and OncologyK05CA160724 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI OEFFINGER, KEVIN CHARLES · 2011 to 2015
$821k
NCI NIH HHS K05 CA160724NCI NIH HHS R01 CA100474NCI NIH HHS R01-CA-100474NCRR NIH HHS M01 RR000633NCRR NIH HHS M01-RR-00633NCRR NIH HHS UL1 RR024982NCRR NIH HHS UL1-RR-024982
6 · The paper itself

Abstract

backgroundFollowing our previous reports of an increased prevalence of insulin resistance and adiposity among acute lymphoblastic leukemia (ALL) survivors, particularly women treated with cranial radiotherapy (CRT), we aimed to (1) assess the relationships between adipokines (leptin and adiponectin), CRT, and measures of body fatness and (2) determine correlates of insulin resistance, by gender.

methodsWe conducted cross-sectional evaluation of 116 ALL survivors (median age: 23.0 years; range: 18-37; average time from treatment: 17.5 years), including fasting laboratory testing (adiponectin, leptin, insulin, and glucose), anthropometric measurements (weight, height, and waist circumference), DXA (total body fat and truncal-to-lower-body-fat ratio), and abdominal CT (visceral fat). We estimated insulin resistance using the homeostasis model for assessment of insulin resistance (HOMA-IR). Analytic approaches included regression models and Wilcoxon rank sum testing.

resultsMean leptin per kilogram fat mass was higher for females (0.7 ng/ml/kg) than males (0.4 ng/ml/kg, P < 0.01), and among subjects who had received CRT compared to those who had not received CRT (females CRT =0.9 ng/ml/kg, no CRT = 0.7 ng/ml/kg; P = 0.1; males CRT = 0.5 ng/ml/kg, no CRT = 0.3 ng/ml/kg; P < 0.01). Elevated HOMA-IR was nearly uniformly present, even among subjects with BMI < 25 kg/m(2), and was associated with higher leptin:adiponectin ratio (LA ratio; P < 0.01).

conclusionsAmong survivors of childhood leukemia, higher leptin levels were associated with measures of body fat and insulin resistance. Anthropomorphic and metabolic changes many years after ALL treatment remain a major health problem facing survivors and may be related to central leptin resistance.

Indexed as

Adipose TissueInsulin ResistanceSurvivorsAdipokinesAdolescentAdultAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapyCranial IrradiationCross-Sectional StudiesFemaleHumansMaleObesityPrecursor Cell Lymphoblastic Leukemia-LymphomaStem Cell TransplantationAdipokines

Identifiers

PMID21254377
PMCPMC3520427
OpenAlexW1972574156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.